BAGSVAERD, DENMARK--(Marketwire - August 12, 2010) -
Novo Nordisk A/S has today entered into an agreement to purchase 5,100,000 B shares (nominal DKK 1) from Novo A/S as part of the ongoing DKK 8.5 billion share repurchase programme for 2010. The transaction price is set to DKK 503.412 per share and has been calculated as the average market price from 5 August to 11 August in the open trading window following the announcement of Novo Nordisk’s financial results for the first six months of 2010.
[HUG#1437410]
Company Announcement no 45 2010: http://hugin.info/2013/R/1437410/382221.pdf
Further information on Novo Nordisk A/S please contact: Media: Investors: Outside North America: Outside North America: Anne Margrethe Hauge Klaus Bülow Davidsen Tel: (+45) 4442 3450 Tel: (+45) 4442 3176 amhg@novonordisk.com klda@novonordisk.com Kasper Roseeuw Poulsen Tel: (+45) 4442 4471 krop@novonordisk.com In North America: In North America: Sean Clements Hans Rommer Tel: (+1) 609 514 8316 Tel: (+1) 609 919 7937 secl@novonordisk.com hrmm@novonordisk.com Further information on Novo A/S please contact: Media: Henrik Gürtler, CEO Tel: (+45) 3527 6575 Thorkil Kastberg Christensen, CFO Tel: (+45) 3527 6592
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
All reproduction for further distribution is prohibited.
Source: Novo Nordisk A/S via Thomson Reuters ONE
